TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA secures contract for Call For Proposals Under The Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M

Portugal, April 29 -- Portugal based TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA has secured contract from Unidade Local De Saude Do Alto Alentejo E.P.E for Call For Proposals Under The Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M. The value of the contract is worth 297500 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....